Welcome to our dedicated page for Castellum news (Ticker: CTM), a resource for investors and traders seeking the latest updates and insights on Castellum stock.
Castellum, Inc. reports news on its federal-government technology services business, including cybersecurity, electronic warfare, software engineering, information technology, and mission-support work. Company updates commonly cover financial results, organic revenue growth, backlog, prime contract wins, recompete awards, and work performed through subsidiaries and joint ventures for defense customers.
Recurring developments also include CMMC Level 2 C3PAO certification, balance-sheet actions such as debt retirement, business development investments, M&A strategy, and product or capability expansion in areas such as extended reality, digital engineering, model-based systems engineering, artificial intelligence, and machine learning-enabled applications.
Castellum (NYSE-American: CTM), a cybersecurity and electronic warfare solutions provider, has announced the formation of a new subsidiary, Castellum Advanced Technology Products, Inc. (CATP). This strategic initiative represents a significant expansion of Castellum's business model, focusing on developing internal technology, partnering with leading-edge tech companies, and potentially taking equity positions in companies with advanced technology relevant to Department of Defense customers.
CEO Glen Ives emphasized that advanced technology deployment is crucial for modern battlefield success. The company aims to enhance its organic growth capabilities and improve its service delivery to government clients through greater control over key products. This strategic shift is expected to drive both revenue growth and operating margin improvements.
Castellum (NYSE-American: CTM), a cybersecurity, electronic warfare, and software engineering services company, has announced details for its 2025 Annual Stockholders Meeting. The meeting is scheduled for May 28, 2025, at 10:00 a.m. ET and will be held both in-person at Pillsbury Winthrop Shaw Pittman LLP's offices in Tysons, VA, and virtually via audio conference.
Stockholders of record as of March 21, 2025, will be eligible to participate. Following the main meeting, management will conduct an informal presentation and Q&A session. The presentation materials will be available on the company's website under the Investor tab prior to the meeting.
Castellum (NYSE-American: CTM) has successfully negotiated a $2 million reduction in principal balance on notes payable to Robert Eisiminger, bringing the total outstanding principal to $4 million. The cybersecurity and electronic warfare services company has also secured an extension of the maturity date to December 15, 2027 on the remaining note.
The complete terms of the amended agreement will be disclosed in an upcoming Form 8-K filing. CFO David Bell emphasized that this debt reduction strengthens their balance sheet, while CEO Glen Ives highlighted how this strategic move supports their organic growth strategy and ability to secure major prime contracts.
Castellum (NYSE-American: CTM) announces that its subsidiary Global Technology and Management Resources (GTMR) has expanded its General Services Administration (GSA) Multiple Award Schedule (MAS) contract by adding Special Item Number (SIN) 541611. This addition enables GTMR to compete for contracts in management and financial consulting, acquisition and grants management support, and business program and project management services.
GTMR's existing GSA MAS contract already includes engineering services (SIN 541330ENG), testing laboratory services (SIN 541380), engineering system design and integration services (SIN 541420), and engineering research and development and strategic planning (SIN 541715). This expansion represents a strategic move from engineering into professional services, allowing the company to respond to additional RFQs and RFPs while leveraging joint venture agreements on the GSA MAS schedule.
Castellum (NYSE-American: CTM) announces the upcoming expiration of remaining warrants from its March 2025 $4.5 million public offering. Of the original 4,500,000 warrants issued at $1.08 per share, 1,145,000 (over 25%) have been exercised, leaving 3,355,000 unexercised warrants that will expire on May 16, 2025.
The company has already raised an additional $1.2 million through warrant exercises through March. The initial public offering in March 2025 consisted of shares priced at $1.00. Management highlights their recent $103 million contract win and strong balance sheet, emphasizing their focus on organic growth and commitment to stakeholders.